Literature DB >> 2903128

Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with the genes for streptolysin O and pneumolysin.

R K Tweten1.   

Abstract

The nucleotide sequence was determined for the gene encoding the thiol-activated cytolysin, perfringolysin O (theta-toxin), from Clostridium perfringens. The nucleotide-sequence-derived primary structure of perfringolysin O is 499 residues long and exhibits a 27-amino-acid signal peptide. The calculated molecular weight of the secreted (mature) form of perfringolysin O is 52,469. The deduced amino-terminal sequence of perfringolysin O is identical to that determined for purified perfringolysin O. Hydropathy analysis indicated that, except for the signal peptide, no major stretches of hydrophobic residues are present. Extensive amino acid sequence homology (65%) was detected with the low-molecular-weight form of streptolysin O, and a lesser amount (42%) was detected with pneumolysin. The nucleotide sequence of the perfringolysin O gene (pfo) exhibits approximately 60% homology with the streptolysin O gene (slo) and 48% homology with the pneumolysin gene (ply). All three toxins contain an identical region of 12 amino acids, which includes the essential cysteine of all three toxins. The location of these 12 residues was conserved in all three toxins when the primary sequences were aligned for maximum homology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903128      PMCID: PMC259730          DOI: 10.1128/iai.56.12.3235-3240.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product.

Authors:  R K Tweten
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

2.  Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.

Authors:  K Mitsui; N Mitsui; J Hase
Journal:  Jpn J Exp Med       Date:  1973-10

3.  Alteration by cereolysin of the structure of cholesterol-containing membranes.

Authors:  J L Cowell; K S Kim; A W Bernheimer
Journal:  Biochim Biophys Acta       Date:  1978-02-21

Review 4.  Termination of transcription in E. coli.

Authors:  W M Holmes; T Platt; M Rosenberg
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

5.  A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides.

Authors:  D Perlman; H O Halvorson
Journal:  J Mol Biol       Date:  1983-06-25       Impact factor: 5.469

6.  Enhanced graphic matrix analysis of nucleic acid and protein sequences.

Authors:  J V Maizel; R P Lenk
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Rapid similarity searches of nucleic acid and protein data banks.

Authors:  W J Wilbur; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

9.  Cloning and expression in Escherichia coli of the streptolysin O determinant from Streptococcus pyogenes: characterization of the cloned streptolysin O determinant and demonstration of the absence of substantial homology with determinants of other thiol-activated toxins.

Authors:  M Kehoe; K N Timmis
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  44 in total

1.  Differential sensitivity of pneumolysin-induced channels to gating by divalent cations.

Authors:  Y E Korchev; C L Bashford; C A Pasternak
Journal:  J Membr Biol       Date:  1992-05       Impact factor: 1.843

2.  Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine.

Authors:  C Geoffroy; J Mengaud; J E Alouf; P Cossart
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

3.  Evidence that Clostridium perfringens theta-toxin induces colloid-osmotic lysis of erythrocytes.

Authors:  R W Harris; P J Sims; R K Tweten
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

4.  Biosynthesis, maturation, and acid activation of the Semliki Forest virus fusion protein.

Authors:  M Kielian; S Jungerwirth; K U Sayad; S DeCandido
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity.

Authors:  M Pinkney; E Beachey; M Kehoe
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

Review 6.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family.

Authors:  S J Billington; B H Jost; W A Cuevas; K R Bright; J G Songer
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

8.  Purification and characterization of two Listeria ivanovii cytolysins, a sphingomyelinase C and a thiol-activated toxin (ivanolysin O).

Authors:  J A Vazquez-Boland; L Dominguez; E F Rodriguez-Ferri; G Suarez
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

9.  Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O.

Authors:  S Jones; D A Portnoy
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  The primary structure of Clostridium septicum alpha-toxin exhibits similarity with that of Aeromonas hydrophila aerolysin.

Authors:  J Ballard; J Crabtree; B A Roe; R K Tweten
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.